colitis-associated colon cancer

Crohn’s disease, ulcerative colitis, and colon cancer treated with experimental breakthrough therapy

Crohn’s disease, ulcerative colitis and colon cancer can be treated with experimental breakthrough therapy. The findings come from UCLA where researchers have found a way to suppress the development of ulcerative colitis by using a chemical inhibitor capable of blocking an RNA molecule (microRNA-214) involved in the transmission of genetic information. High levels of microRNA-214 ...click here to read more